MAR:NASDAQ

Marriott International

Data as of 2026-03-10 - not real-time

$328.86

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Marriott (MAR) is trading at $328.86, comfortably above its 20‑day SMA of 344.28 and 50‑day SMA of 329.33, but still below the 200‑day SMA of 287.40, indicating a short‑term bullish bias within a longer‑term uptrend. The RSI sits at 44.8, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, flagging potential short‑term pressure. Volume is trending downwards and 30‑day volatility is high at roughly 34%, with a beta of 1.06, reflecting sensitivity to market swings; the Fear & Greed Index reads “Extreme Greed,” supporting the upside potential. Analyst consensus projects a mean target of $354.72, implying about an 8% upside, and the company has issued 2026 RevPAR guidance of +1.5‑2.5%, complemented by a 7% jump in Q4 fee revenue and a 16% rise in incentive management fees. Fundamentals show a solid gross margin of 94% and operating cash flow of $3.2 B, but a high PE of 34.5 and negative book value per share raise valuation concerns. The dividend yield of 0.83% with a payout ratio under 30% appears sustainable given strong free cash flow, while the debt load is sizable yet offset by ample cash and a moderate debt‑to‑equity profile. Overall, the stock sits at a technically supportive level with modest upside, a resilient earnings outlook, and a dividend that adds defensive appeal.

Trading Recommendations

Short Term

< 1 year
hold
Conviction: 6/10

Key Factors

  • Price above 20‑day and 50‑day SMAs providing technical support
  • Bearish MACD histogram and decreasing volume signaling short‑term weakness
  • Neutral RSI and strong market sentiment limiting downside risk

Medium Term

1–3 years
buy
Conviction: 8/10

Key Factors

  • Analyst target price suggests ~8% upside
  • 2026 RevPAR guidance (+1.5‑2.5%) and robust fee‑revenue growth
  • Sustainable dividend yield and solid operating cash flow

Long Term

> 3 years
buy
Conviction: 7/10

Key Factors

  • Diversified global brand portfolio and expanding loyalty program
  • Consistent revenue growth and high gross margins
  • Manageable debt profile supported by strong free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth4.20%
Profit Margin9.88%
P/E Ratio34.5
ROA9.63%
P/B Ratio-23.2
Op. Cash Flow$3.2B
Free Cash Flow$1.7B

Technical Analysis

TrendBullish
RSI44.8
Support$311.20
Resistance$370.00
MA 20$344.28
MA 50$329.33
MA 200$287.40
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89

Valuation

Fair Value$41.21
Target Price$354.72
Upside/Downside7.86%
GradeFair
TypeBlend
Dividend Yield0.83%

Risk Assessment

Beta1.06
Volatility33.77%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.